Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma - Wikidata - wikimedia - TriplyDB

Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma

Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma

http://www.wikidata.org/entity/Q33868572

about

Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma Biomarkers and severe asthma: a critical appraisal Biomarkers for the Phenotyping and Monitoring of Asthma in Children Development of New Therapies for Severe Asthma Effect of nanoparticles exposure on fractional exhaled nitric oxide (FENO) in workers exposed to nanomaterials Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program.Biomarkers in asthma: a real hope to better manage asthma.Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium.Evolving Concepts of Asthma.Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study Longitudinal assessment of high versus low levels of fractional exhaled nitric oxide among children with asthma and atopy.Epigenetic regulation: the interface between prenatal and early-life exposure and asthma susceptibility.Cardiovascular biomarkers in exhaled breath Advances in pediatric asthma in 2010: addressing the major issues Severe Asthma: The Evolution of Patient-directed Management Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways.Elevated levels of NO are localized to distal airways in asthma Exhaled nitric oxide and clinical phenotypes of childhood asthma.Update in asthma 2010.Biomarker-based asthma phenotypes of corticosteroid response.An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.Predicting asthma exacerbations in children Metabolomic Endotype of Asthma.Severe asthma in childhood: recent advances in phenotyping and pathogenesis.Imaging pulmonary inducible nitric oxide synthase expression with PET.Nitric oxide and asthma severity: towards a better understanding of asthma phenotypes.Update in asthma 2011.Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.Respiratory Health Risks for Children Living Near a Major Railyard.Severe Asthma in Children: Lessons Learned and Future Directions.Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.A mobile instrumentation platform to distinguish airway disorders.Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation.Role of exhaled nitric oxide as a predictor of atopy.Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.

P2860

Q26771615-8D0D23F4-DF96-4D7B-B53C-ACF801AF145B Q26772201-EE7CAE38-9B27-4706-B8AB-92BFA6CF8147 Q26782718-3792D15B-FEEF-4EE0-81E4-344AE67DA283 Q28072326-57B658CF-EB66-4F76-9AE2-72CA7DEA44C9 Q28077546-5BA73C13-DBDF-4782-AC95-FCA9DE1CA393 Q28395218-9681F183-5223-42A3-97F9-04E0F94C5E8A Q30277842-9BDDC060-2853-4588-BE5F-D7AA32BC2FB8 Q30407742-0833E37A-5CB8-49B8-8E4E-12BC37DECC6C Q30417360-D750B519-4018-4D07-B21E-A1D86C10052C Q30422401-DBA51D14-D9B9-4671-BD6B-03C7E054312D Q33610976-2871C325-D840-418D-A15F-EB5F1F30BB88 Q33735605-4C8AF5BA-45A2-4538-93C6-063453AF43F3 Q33755995-6E8F7187-2463-44DE-961F-424F4A0C52A0 Q33926448-17C3731F-1555-4DB4-8376-A2F9645360CE Q34105404-CF76F639-EAC5-4213-9BBD-DCEA177F7A1A Q34384531-D9D2633D-388E-4C8C-8CDE-125D0B246E7C Q34545186-0AE1D5AB-A93F-4B12-B106-636EC748F8B1 Q34858558-5D405B21-06AC-4E0C-BD14-0652A45D0197 Q34960273-36DC6ACB-2742-4AB2-BFA5-5C59461AD206 Q35072967-053B9E27-AD95-42BE-A0FB-FE2237FB892E Q35078159-2C946761-18BD-4096-8CCA-986391C5687E Q35219714-35BCC18F-C427-445C-A479-C2115512E344 Q35305384-CCED4F7D-27D3-4CF5-BB9A-987D8BBBDB80 Q35534747-A1FEED2E-CD85-4354-B7AA-F166F88D1210 Q35811718-476E8C7B-E0EB-49A7-89BF-B0C77DCE91EE Q35815608-4633CA53-5764-4B4F-A96E-7315FF578B04 Q35848235-9B51AF0C-1205-463F-A5B3-7705BD1CBB97 Q35849789-D377DC82-4318-4FE4-A453-E8CE8244F072 Q35910735-F33CA1F5-1B7E-4E76-A966-145D2F86788A Q36105881-27386939-4E85-4A89-8D24-08F7393B91EF Q36292443-589B2094-6B4A-44C7-9786-530091490199 Q36437627-0CD7B683-DD43-4EF5-A4A1-D186EFBED6A5 Q36471091-AC0DFF77-0181-4D8F-AA7F-FB317C41DC91 Q36765753-93CC21B8-5564-46D5-8A4B-54DA68581FC2 Q36787683-C4D390E7-16A4-44A7-90A5-242DB0654EED Q36828893-12894F14-5F27-462F-BACB-214C904BBE9F Q36832237-0AE85D7F-9B8E-427F-BF12-9B62E75DFD68 Q36846745-DBE4E81A-7F10-459D-9137-3D954B293DD8 Q36865999-415F7BC0-6360-4F5D-842E-C0C8D4D5BE7A Q36991115-5F6559FC-4DC7-40CE-B254-6F517BEA871C

P2860

Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma

http://www.wikidata.org/entity/Q33868572

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Use of exhaled nitric oxide me ...... ype among patients with asthma

@ast

Use of exhaled nitric oxide me ...... ype among patients with asthma

@en

type

label

Use of exhaled nitric oxide me ...... ype among patients with asthma

@ast

Use of exhaled nitric oxide me ...... ype among patients with asthma

@en

prefLabel

Use of exhaled nitric oxide me ...... ype among patients with asthma

@ast

Use of exhaled nitric oxide me ...... ype among patients with asthma

@en

P1433

Q33868572-99AE4240-42F9-453C-BB43-D6534742C399

P1476

Q33868572-4A976AB7-44FB-4DD4-B12F-0307C280AFBF

P2093

Q33868572-155EA4EF-B6DC-4B81-B9A8-58F44ACC5C07

Q33868572-16848E2C-93C3-40E1-95F3-A6FF81FBB299

Q33868572-243DAE41-CBC5-449C-927E-02934EEB6D4F

Q33868572-491ED197-04B0-4304-B396-E3EE351CF43D

Q33868572-5F54C212-834F-430E-AD54-B7C7EBF6ABE3

Q33868572-73A01B44-CA7D-449C-B85E-D79C7359E9CB

Q33868572-7693E09E-D219-4E7F-A214-337667603253

Q33868572-79B0C5DF-0DF8-4F26-8B01-AD8B779DC374

Q33868572-84029065-4EBC-496C-8917-8BA331B00EEC

Q33868572-8F39419F-F439-4101-BF56-27AACA9D96C9

P2860

Q33868572-039EBBC3-05FC-4A92-A984-4E1F4597B77E

Q33868572-05E24F61-6AE6-47E4-9B27-2D8CED4A3986

Q33868572-0BD613DE-7F9B-4659-8DA6-D785C228945E

Q33868572-1168C88D-D181-47FB-8F97-4ACCD9B93655

Q33868572-18CE20D4-792C-4BFD-ABDE-17446E7F90C3

Q33868572-222C4608-8827-450F-8FC7-70A9A2B3FC81

Q33868572-282B22F6-F2B9-4FC9-818C-0B5B76F7C256

Q33868572-28F1AF33-4952-473F-87DF-8AF70D637C67

Q33868572-2C408894-17EB-43EF-BAB5-4F464CC54A3B

Q33868572-2D3C9CE5-A99F-4300-A0D4-C4453A8E2865

P304

Q33868572-6FBA9A18-7889-43F9-9BF1-754CB5161D8D

P31

Q33868572-CCB0B16B-0CE4-460C-97C3-56B8FF71E7C4

P356

Q33868572-05C3A913-EB15-4166-AD0D-6ADADFA2CBC3

P407

Q33868572-8DFB7D99-262F-40BB-A9BB-64CB4BB01215

P433

Q33868572-7A916913-7DFA-4714-95E7-ECAB5C1B1E7F

P478

Q33868572-E3A8A7D2-51BD-4F31-93F1-873932D48086

P50

Q33868572-D0E821EC-5509-4142-8229-65FEF3FD180C

Q33868572-DD0D3A90-7719-4265-9399-9539BA4A9FFD

P577

Q33868572-E4E61062-1361-4F20-9116-DAA358832D68

P698

Q33868572-51979738-1CCE-4D4C-B4A6-D4DCA931F83E

P921

Q33868572-F9AD053A-575E-4AD6-8D33-73A0AC3550B5

P932

Q33868572-2769850E-3212-44F1-80AA-9D779C6B979F

P356

RCCM.200905-0695OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Use of exhaled nitric oxide me ...... ype among patients with asthma

@en

P2093

Benjamin Gaston

http://www.w3.org/2001/XMLSchema#string

Douglas Curran-Everett

http://www.w3.org/2001/XMLSchema#string

Elliot Israel

http://www.w3.org/2001/XMLSchema#string

Gerald Teague

http://www.w3.org/2001/XMLSchema#string

Jeffrey Hammel

http://www.w3.org/2001/XMLSchema#string

Kian Fan Chung

http://www.w3.org/2001/XMLSchema#string

Mario Castro

http://www.w3.org/2001/XMLSchema#string

National Heart, Lung, and Blood Institute Severe Asthma Research Program

http://www.w3.org/2001/XMLSchema#string

Nizar Jarjour

http://www.w3.org/2001/XMLSchema#string

Raed A Dweik

http://www.w3.org/2001/XMLSchema#string

P2860

Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma

Protection from experimental asthma by an endogenous bronchodilator

Asthma phenotypes

Standardisation of the measurement of lung volumes

Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness

Standardization of Spirometry, 1994 Update. American Thoracic Society

Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide.

NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Pathophysiology of severe asthma.

P304

1033-1041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200905-0695OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P50

William W Busse

Eugene R Bleecker

P577

2010-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20133930

http://www.w3.org/2001/XMLSchema#string

P921

P932

2874447

http://www.w3.org/2001/XMLSchema#string